Sulphonamides: N-methylperfluorooctane sulphonamide

In 2024, sulphonamides: n-methylperfluorooctane sulphonamide trade exhibited significant decline, with global flows reaching $10,488,454 and a three-year compound annual growth rate of -4.2% (five-year: +0.1%). The all-time peak of $61,335,166 was recorded in 2017; the current level is 83% below that high-water mark.

Over the 30-year observation window (1995–2024), 59% of years recorded positive growth, indicating a mildly upward trajectory with periodic contractions. Trend momentum is steady (+2.7% acceleration).

The supply side is moderately concentrated (Herfindahl-Hirschman Index 0.161). The three largest exporters — Ireland ($14.6M), Italy ($5.5M), and Barbados ($3.3M) — collectively dominate supply flows. The leading exporter has grown at +209.6% over the last three years.

On the demand side, importer concentration is moderately concentrated (HHI 0.161). The three largest import markets are Egypt ($3.1M), France ($2.6M), and Oman ($876.2K). The largest importing market sources from 5 different supplying countries.

The dominant trade corridor is Ireland → Egypt at $10.7M, representing 69.1% of the importer's total demand.

The volatility score for sulphonamides: n-methylperfluorooctane sulphonamide is 28 out of 100, classified as low. Trade flows are relatively stable compared to other HS6 products, suggesting mature supply chains and predictable demand.

For market entrants, contracting demand signals caution before committing resources. A moderately concentrated market rewards differentiated positioning and strategic partner selection.

Data confidence is rated "High" based on reporting coverage and consistency across OECD member and partner countries.